An analysis of 79 RA patients revealed that serum exosome-encapsulated miR-6089 was significantly reduced in RA patients and may regulate inflammatory responses by directly targeting TLR4 signaling (110). The gene discussed is TLR4; the disease is rheumatoid arthritis.